The F2-isoprostane 8-epiprostaglandin F(2α) increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 8, 1998, Pages 1248-1256

  Minuz, Pietro ^a,b   Andrioli, Giuseppe ^a   Degan, Maurizio ^a   Gaino, Stefania ^a   Ortolani, Riccardo ^a   Tommasoli, Rosamaria ^a   Zuliani, Valeria ^a   Lechi, Alessandro ^a   Lechi, Clara ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b POLICLINICO BORGO ROMA   (Italy)

Author keywords

F2 isoprostanes; Nitric oxide; Platelet adhesion

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ANTITHROMBOCYTIC AGENT; BIPHENYL DERIVATIVE; CALCIUM; DRUG DERIVATIVE; FIBRINOGEN RECEPTOR; HEPTANOIC ACID DERIVATIVE; ISOPROSTANE DERIVATIVE; PADGEM PROTEIN; THROMBOXANE RECEPTOR; VAPIPROST; VASOCONSTRICTOR AGENT;

ARTICLE; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIGAND BINDING; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ADULT; BLOOD; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; METABOLISM; THROMBOCYTE; THROMBOCYTE ADHESIVENESS; VASCULAR ENDOTHELIUM;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADULT; BIPHENYL COMPOUNDS; BLOOD PLATELETS; CALCIUM; CELLS, CULTURED; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; F2-ISOPROSTANES; HEPTANOIC ACIDS; HUMANS; NITRIC OXIDE; P-SELECTIN; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, THROMBOXANE; VASOCONSTRICTOR AGENTS;

EID: 0031594836     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.8.1248     Document Type: Article

References (13)

1. 2α-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87:9383-9387.
2. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A. 1992;89:10721-10725.
3. Awad JA, Morrow JD, Hill KE, Roberts LJ II, Burk RF. Detection and localization of lipid peroxidation in selenium- and vitamin E-deficient rats using F2-isoprostanes. J Nutr. 1994;124:810-816.
4. Morrow JD, Minton TA, Badr KF, Roberts LJ II. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2-α, is formed in vivo. Biochim Biophys Acta. 1994;1210:244-248.
5. Gopaul NK, Nourooz-Zadeh J, Mallet AI, Änggård EE. Formation of F2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 1994;348:297-300.
6. Lynch SM, Morrow JD, Roberts LJ II, Frei B. Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest. 1994;93:998-1004.
7. 2-isoprostanes) in smokers. N Engl J Med. 1995;332: 1198-1203.
8. 2α; excretion in man. J Pharmacol Exp Ther. 1995;275:94-100.
9. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 1995;368: 225-229.
10. 2α in familial hypercholesterolemia: evidence of oxidative stress in vivo. Circulation. 1996;94(suppl I):I-638. Abstract.
11. 2α, in the rat. J Clin Invest. 1992;90:136-141.
12. 2α in isolated perfused rat lung. J Appl Physiol. 1993;74:460-465.
13. Fukunaga M, Makita N, Roberts LJ, Morrow JD, Takahashi K, Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264:1619-1624.